These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9360063)

  • 1. Drug treatment and schizophrenia in the 1990s.
    Litherland S
    Drugs; 1997 Nov; 54(5):794. PubMed ID: 9360063
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac risk and schizophrenia.
    Jindal R; MacKenzie EM; Baker GB; Yeragani VK
    J Psychiatry Neurosci; 2005 Nov; 30(6):393-5. PubMed ID: 16327872
    [No Abstract]   [Full Text] [Related]  

  • 3. Late potentials in the signal-averaged electrocardiogram in schizophrenia patients maintained on antipsychotic agents: a preliminary naturalistic study.
    Nahshoni E; Strasberg B; Imbar S; Rotem O; Gur S; Hermesh H; Weizman A
    Eur Neuropsychopharmacol; 2010 Mar; 20(3):146-52. PubMed ID: 20053540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine associated pericarditis and elevated troponin I.
    Kay SE; Doery J; Sholl D
    Aust N Z J Psychiatry; 2002 Feb; 36(1):143-4. PubMed ID: 11929456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate impact of electroconvulsive therapy on cardiac autonomic function in schizophrenia: a preliminary study.
    Lai IC; Wang YC; Yang CC; Kuo TB; Shieh KR
    Schizophr Res; 2008 Mar; 100(1-3):353-5. PubMed ID: 18060743
    [No Abstract]   [Full Text] [Related]  

  • 7. High dose of multiple neuroleptic treatments for schizophrenia in Japan: dose reduction and electrocardiographic changes.
    Kawai N; Yamakawa Y; Hori T; Tachikawa H; Asada T
    J Clin Psychopharmacol; 2005 Apr; 25(2):186-8. PubMed ID: 15738754
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose ziprasidone in treatment-resistant schizophrenia and affective spectrum disorders: a case series.
    Deutschman DA; Deutschman DH
    J Clin Psychopharmacol; 2007 Oct; 27(5):513-4. PubMed ID: 17873687
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia].
    Gury C; Canceil O; Iaria P
    Encephale; 2000; 26(6):62-72. PubMed ID: 11217540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocarditis after overdose of conventional antipsychotics.
    Bhatia MS; Gupta R; Dhawan J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):606-8. PubMed ID: 17965989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of olanzapine on the PR and QT intervals in patients with schizophrenia.
    Suzuki Y; Ono S; Tsuneyama N; Sawamura K; Sugai T; Fukui N; Watanabe J; Someya T
    Schizophr Res; 2014 Jan; 152(1):313-4. PubMed ID: 24275577
    [No Abstract]   [Full Text] [Related]  

  • 13. The tachycardic schizophrenic.
    Hoefen RJ
    Cardiol J; 2010; 17(3):314-5. PubMed ID: 20535726
    [No Abstract]   [Full Text] [Related]  

  • 14. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
    Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risks of atypical antipsychotic drug treatment.
    Drici MD; Priori S
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of schizophrenia: advances during the decade of the brain.
    Buckley PF
    Br J Hosp Med; 1996 Dec 11-1997 Jan 14; 56(11):574-80. PubMed ID: 8982483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible association between high normal and high dose olanzapine and prolongation of the PR interval.
    Kosky N
    J Psychopharmacol; 2002 Jun; 16(2):181-2. PubMed ID: 12095078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophrenia.
    Lopez LV; Kane JM
    J Clin Psychiatry; 2015 Sep; 76(9):1249-50. PubMed ID: 26455671
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
    Gazdag G; Tolna J; Bitter I
    Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of schizophrenia: current concepts.
    Naber D; Hippius H
    Pharmacopsychiatry; 1991 Mar; 24(2):43-4. PubMed ID: 1677202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.